By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) 

245 First Street
Suite 1800
Cambridge  Massachusetts  02142  U.S.A.
Phone: 503-227-0554 Fax: 503-227-0751


SEARCH JOBS


Industry
Biotechnology






Company News
Sarepta (SRPT) Announces Fourth Quarter And Full-Year 2014 Financial Results And Recent Corporate Developments 2/26/2015 11:43:19 AM
Sarepta (SRPT) To Present Company Overview At Upcoming Conferences 2/24/2015 11:10:19 AM
Sarepta (SRPT) To Announce Fourth Quarter And Full-Year 2014 Financial Results And Corporate Update On February 26, 2015 2/19/2015 12:31:10 PM
Despite CEO's Comments, Experimental Sarepta (SRPT) Drug Protects Lab Monkeys From Ebola 2/11/2015 6:21:58 AM
BIOCEO15: Sarepta (SRPT) CEO Feels Backlash After Saying Ebola Research Isn’t in "Shareholder Interest" 2/9/2015 11:36:10 AM
Sarepta (SRPT) To Present Company Overview At Upcoming Conferences 2/4/2015 10:40:27 AM
BioMarin (BMRN), Sarepta (SRPT) Rivalry Gets Nasty in Battle Over Data 1/19/2015 6:07:38 AM
Sarepta (SRPT) Announces First Patient Dosed In European Phase1/2 Study Of SRP-4053 In Duchenne Muscular Dystrophy Patients 1/14/2015 7:56:48 AM
Breaking: J.P. Morgan: BioMarin (BMRN) Takes Shot at Sarepta (SRPT), Says DMD Drug Has Better Results So Far 1/12/2015 5:12:05 PM
Sarepta Therapeutics (SRPT) Reports Long-Term Outcomes Through 168 Weeks From Phase 2b Study Of Eteplirsen In Duchenne Muscular Dystrophy 1/12/2015 12:10:20 PM
12345678910...
//-->